VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,081,137 | -8.0% | 531,211 | -9.8% | 4.93% | -14.4% |
| Q2 2023 | $29,425,197 | +19.1% | 589,211 | -10.6% | 5.76% | +18.7% |
| Q1 2023 | $24,707,228 | -35.6% | 659,211 | -17.6% | 4.85% | -35.5% |
| Q4 2022 | $38,360,000 | +166.4% | 800,000 | +33.3% | 7.52% | +116.9% |
| Q3 2022 | $14,400,000 | -32.8% | 600,000 | -39.1% | 3.47% | -32.6% |
| Q2 2022 | $21,437,000 | +0.3% | 985,153 | +11.3% | 5.14% | -0.5% |
| Q1 2022 | $21,376,000 | +79.7% | 885,153 | +77.0% | 5.17% | +95.5% |
| Q4 2021 | $11,895,000 | +378.1% | 500,000 | +409.9% | 2.64% | +356.5% |
| Q3 2021 | $2,488,000 | – | 98,061 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |